Improved clinical, functional and work outcomes in spondyloarthritides during real-life adalimumab treatment in central-eastern Europe

导出原文传递

翻译打印收藏纠错

作者： Szanto, Sandor ^[1] ; Poor, Gyula ^[2] ; Opris, Daniela ^[3] ; Iaremenko, Oleg ^[4] ; Prochazkova, Leona ^[5] ; Kuuse, Reet ^[6] ; Nagy, Orsolya ^[7] ; Chernyshov, Valentyn ^[8] ; Geher, Pal ^[9]

作者单位： AbbVie Ltd, Budapest, Hungary ^[1] Sf Maria Clin Hosp, Bucharest, Romania ^[2] St Annes Univ Hosp Brno, Div Rheumatol, Dept Internal Med 2, Brno, Czech Republic ^[3] Hospitaller Bros St John God Hosp, Budapest, Hungary ^[4] Univ Debrecen, Dept Rheumatol, Fac Med, Debrecen, Hungary ^[5] Natl Inst Rheumatism & Physiotherapy, Budapest, Hungary ^[6] Natl Med Univ, Kiev, Ukraine ^[7] AbbVie Biopharmaceut GmbH, Minsk, Byelarus ^[8] Tartu Univ Hosp, Tartu, Estonia ^[9]

关键词 adalimumab ankylosing spondylitis extra-articular manifestations observational study psoriatic arthritis workability

发布时间 2017-04-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交